{"disease":{"id":"clonal-hematopoiesis","name":"clonal hematopoiesis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02958462","title":"Pre-myeloid Cancer and Bone Marrow Failure Clinic Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06295965","title":"Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT04541654","title":"Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT04987268","title":"CHIP and Residual Cardiovascular Event Tendency After Smoking Cessation","phase":"","overall_status":"COMPLETED","enrollment_count":1029,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT04689750","title":"Donor CHIP and Allogeneic HSCT Outcome","phase":"","overall_status":"RECRUITING","enrollment_count":850,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT06701214","title":"The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Vanderbilt-Ingram Cancer Center","has_results":false},{"nct_id":"NCT04102423","title":"CHIP/CCUS Natural History Protocol","phase":"","overall_status":"RECRUITING","enrollment_count":306,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT05705531","title":"A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma","phase":"","overall_status":"RECRUITING","enrollment_count":190,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT07362966","title":"Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT06097663","title":"A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05246813","title":"Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)","phase":"","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Imelda Hospital, Bonheiden","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}